SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Equities
002864
CNE1000032C9
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.5 CNY | -0.04% |
|
-0.40% | -28.55% |
SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent drugs. The Company's main product is Panlong Qipian, which is for the treatment of orthopedic rheumatism diseases. The Company also provides other Chinese patent drugs for the treatment of hepatobiliary, cardiovascular and cerebrovascular, gynecological and anti-tumor diseases. The Company is also involved in the production and sales of Chinese herbal pieces, as well as the medical commercial distribution business. The Company distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
19/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -28.55% | 399M | |
| +50.70% | 791B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B |
- Stock Market
- Equities
- 002864 Stock
- News Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
- Panlong Pharmaceutical Gets Certificate for Shaanxi Good Trademark